Marie A. Scully

Uclh

London, ENG, GB

Expertise in

conditions

Uclh

London, ENG, GB

OverviewLocationsClinical Research

Overview

Marie Scully practices in London, United Kingdom. Ms. Scully is highly rated in 16 conditions, according to our data. Her top areas of expertise are Purpura, Thrombocytopenia, Blood Clots, Adult Immune Thrombocytopenia, and Splenectomy.

Her clinical research consists of co-authoring 177 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Female

Locations

UCLH
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura

Enrollment Status: Completed

Publish Date: December 11, 2023

Intervention Type: Drug

Study Drug: Fostamatinib

Study Phase: Phase 3

A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-blind Study in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) to Evaluate the Pharmacokinetics, Safety and Efficacy of rADAMTS-13 (SHP655) Administered in Addition to Standard Of Care (SoC) Treatment

Enrollment Status: Completed

Publish Date: December 01, 2022

Intervention Type: Other, Drug

Study Drug: SHP655

Study Phase: Phase 2

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

Enrollment Status: Completed

Publish Date: March 17, 2021

Intervention Type: Other

A Phase II Pilot Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients With Low ADAMTS13 Activity

Enrollment Status: Terminated

Publish Date: September 13, 2019

Intervention Type: Biological

Study Phase: Phase 2

A Phase 1b Open-Label, Dose Escalation Study of PRTX-100 in Adult Patients With Persistent/Chronic Immune Thrombocytopenia

Enrollment Status: Terminated

Publish Date: March 25, 2019

Intervention Type: Drug

Study Phase: Phase 1/Phase 2

View 4 Less Clinical Trials

177 Total Publications

Demystifying autoimmune HIT: what it is, when to test, and how to treat.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 07, 2024

View All 177 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Scully's expertise for a condition

ConditionClose